Skip to main content

Genotyping Assay Market Worth USD 31.9 Billion : Decreasing Prices Of DNA Sequencing

 Major Growth Boosters:

The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing. The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years. The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.

What This Report Will Provide?

Genotyping platforms have several potential application areas such as pharmacogenomics, diagnostic research, personalized medicine, and forensics. Furthermore, this technology is also apt for a range of veterinary needs, food safety and quality, and environmental testing in remote areas and industrial settings. At present, human diagnostics and pharmacogenomics offer significant marker potential as these segments require rapid genotyping analysis on a large scale due to the need for better treatment options and high disease prevalence.

Expected Revenue Growth:

MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (OTC:CAGR) of 22.0% during the forecast period.



 Recent Developments

  • In May 2018, Agilent technologies opened a new logistics center in Texas to increase its capacity for house inventory and to fulfill the growing demand for NGS products from its genomics group.
  • In March 2018, Danaher Corporation acquired Integrated DNA Technologies Inc. (US). This acquisition strengthened Danaher’s Life Sciences platform. IDT will operate as a standalone operating company and brand within Danaher Corporation.
  • In January 2018, Thermo Fisher Scientific signed a partnership with Illumina (US) that enabled Illumina to sell the Ion AmpliSeq technology to researchers who conduct scientific studies using Illumina’s next-generation sequencing (NGS) platforms.
  • In January 2018, Illumina launched the iSeq 100 Sequencing System.
  • In January 2018, Thermo Fisher Scientific launched the Ion GeneStudio S5 Series Instrument.

Key Questions Addressed in The Report:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the genotyping market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading players operating in this market?
  • What are the opportunities for new market entrants?

Request Sample Report:   ttps://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595 

Technological Advancements and Decreasing Prices of DNA Sequencing

Technical advancements have allowed for miniaturization, automation, and reduced overall costs, as well as operational flexibility and the incorporation of multi-parameter testing. All of these have greatly helped increase the applications and convenience of DNA sequencing, allowing physicians to focus on high-level decision-making such as identifying and prioritizing drug targets through various genotyping studies. This has directly boosted the uptake of PCR, sequencing, capillary electrophoresis, and microarray technologies in fields such as drug discovery and clinical research.

Regional Growth Analysis:

North America is expected to hold the largest market size in the global genotyping market during the forecast period, followed by the European region. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

Download PDF Brochure:     https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595 

Labels:

Comments

Post a Comment

Popular posts from this blog

Biomaterials Market To Reach USD 47.5 billion by 2025 - Rising demand for medical implants

  What This Report Will Provide? This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Expected Revenue Growth: [298 Pages Report]  The global  biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Major Growth Boosters: Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing res...
Post a Comment
Read more

Benefits of Best Accounting Software by 360Quadrants

  Accounting software  can manage the businesses in several different ways, based on the key characteristics and goals. Accounting systems provide all kinds of bonuses, from simpler invoicing to complicated tax reporting, that is not even possible without a correct framework. Simplification  - Accounting software put control of funds in the hands of a non-accounting crowd, aimed at giving significance to statistics while executing electronic computations. With hardly any training, the company owner can execute all financial transactions and meet the legal requirements from a desktop computer or smartphone, even without having to pay a third party to keep the expenditure in the loop. Cost reduction  - Accounting and finance frameworks simplify key estimates and operating processes and gain a charge of the sales process and you don't need to outsource financial services to an external specialist. They also raise printing and storage prices and store confidential data i...
Post a Comment
Read more

Biomaterials Market To Reach $ 47.5 Billion – Increasing Research On Regenerative Medicine

  Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years. [298 Pages Report]  The  global biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Market Dynamics Increased funds and grants by government bodies and universities for the development of novel biomaterials Increasing demand for implantable devices Growing demand for biomaterials in plastic surgery and wound healing applications Rising incidence of cardiovascular diseases Increasing research on regenerative medic...
Post a Comment
Read more